CN Stock MarketDetailed Quotes

002224 Sanlux Co.,Ltd.

Watchlist
  • 4.03
  • +0.02+0.50%
Not Open Jun 19 15:00 CST
3.64BMarket Cap53.03P/E (TTM)

Sanlux Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
28.93%1.48B
-19.66%912.9M
-19.13%912.74M
-7.02%1.04B
3.82%1.15B
-10.44%1.14B
2.76%1.13B
5.77%1.12B
1.78%1.11B
11.84%1.27B
Transactional financial assets
-13.89%94.03M
-0.38%100.8M
6.21%104.84M
-16.29%103.1M
10.09%109.19M
-18.80%101.18M
-25.02%98.71M
-8.02%123.16M
-27.74%99.18M
-31.02%124.61M
Notes receivable and accounts receivable
-28.13%124.03M
31.90%120.11M
-8.40%123.74M
-7.41%117.96M
32.60%172.58M
-18.93%91.06M
20.27%135.08M
32.10%127.41M
42.13%130.15M
50.92%112.32M
-Notes receivable
9.07%10.54M
11.99%24.57M
5.83%13.16M
2.26%13.33M
-20.36%9.67M
-9.46%21.94M
3,178.18%12.43M
3,972.80%13.03M
5,509.11%12.14M
14,152.52%24.24M
-Accounts receivable
-30.34%113.49M
38.22%95.53M
-9.84%110.58M
-8.52%104.63M
38.05%162.92M
-21.54%69.12M
9.57%122.65M
18.98%114.38M
29.18%118.01M
18.63%88.09M
Other receivables (including interest and dividends)
89.39%27.65M
-37.60%24.79M
-96.96%1.61M
-73.19%14.79M
-76.09%14.6M
35.97%39.72M
1,544.19%52.97M
2,361.84%55.16M
3,536.44%61.06M
1,701.74%29.21M
-Accrued interest receivable
----
----
----
--0
----
----
----
----
----
----
-Other receivable
----
----
----
-73.19%14.79M
----
35.97%39.72M
----
2,361.84%55.16M
----
1,701.74%29.21M
Advance payment
37.57%47.46M
46.13%20.76M
202.42%37.18M
60.91%23.85M
58.45%34.5M
-2.25%14.21M
-78.54%12.29M
-64.40%14.82M
-46.68%21.77M
-64.81%14.53M
Inventories
-19.62%220.31M
-35.86%193.96M
-2.08%291.52M
-14.42%262.58M
-11.55%274.11M
5.55%302.39M
0.78%297.72M
4.20%306.82M
22.94%309.91M
46.02%286.48M
Receivable financing
-65.56%1.84M
-15.73%3.09M
499.63%6.32M
97.98%6.85M
88.51%5.36M
-29.83%3.66M
-84.80%1.05M
-76.56%3.46M
-68.21%2.84M
-77.46%5.22M
Other current assets
433.48%46.14M
283.34%34.22M
30.72%14.97M
47.83%15.07M
-69.87%8.65M
-58.69%8.93M
-51.53%11.45M
-56.89%10.2M
23.82%28.71M
-25.24%21.61M
Total current assets
15.55%2.04B
-16.90%1.41B
-14.10%1.49B
-9.96%1.58B
0.44%1.77B
-8.87%1.7B
0.53%1.74B
1.89%1.76B
3.24%1.76B
3.65%1.86B
Non Current assets
Other equity investment
2.22%7.4M
2.22%7.4M
-2.14%7.24M
-2.14%7.24M
-0.87%7.24M
-2.14%7.24M
-37.28%7.4M
-46.16%7.4M
-40.34%7.3M
-39.56%7.4M
Other non-current financial assets
-0.18%31.62M
-0.18%31.62M
1,714.85%31.67M
1,714.85%31.67M
1,695.45%31.67M
1,684.62%31.67M
-32.87%1.75M
-32.87%1.75M
-32.15%1.76M
-31.74%1.77M
Investment real estate
----
----
44.61%123.02M
44.55%124.48M
47.16%125.93M
47.09%127.38M
21.61%85.07M
21.67%86.12M
18.76%85.57M
19.58%86.6M
Long-term equity investment
-0.67%77.33M
-16.80%64.78M
-11.34%76.02M
-11.09%76.73M
4.76%77.86M
130.66%77.86M
204.23%85.73M
2,837.38%86.29M
--74.32M
--33.75M
Fixed assets
----
----
----
-11.27%499.85M
----
-6.71%519.35M
----
-5.02%563.34M
----
2.92%556.68M
Constru in process
----
----
----
213.21%390.5M
----
97.12%159.74M
----
121.19%124.68M
----
0.11%81.04M
Productive biological assets
-3.64%135.37M
-3.61%136.65M
-3.58%137.93M
-3.54%139.21M
-4.25%140.49M
-3.48%141.77M
-3.45%143.05M
-3.42%144.33M
-2.65%146.73M
-3.36%146.88M
Intangible assets
8.32%220.8M
0.03%206.05M
-7.26%201.41M
-7.31%202.54M
-7.38%203.83M
-6.99%205.99M
-3.11%217.17M
-3.32%218.52M
-2.39%220.07M
-2.61%221.48M
Development expenditure
----
----
----
----
----
----
--0
--0
----
----
Goodwill
--157.93K
--157.93K
----
----
----
----
----
----
----
----
Long deferred expense
26.98%4.31M
47.52%4.61M
103.80%5.75M
-11.93%2.91M
-15.89%3.39M
-33.71%3.13M
-11.71%2.82M
-5.68%3.31M
-2.87%4.03M
-3.36%4.72M
Deferred tax assets
22.84%52.37M
9.74%49.14M
-11.71%43.73M
2.57%44.12M
-12.51%42.63M
6.55%44.78M
29.08%49.53M
12.04%43.02M
38.98%48.73M
164.80%42.02M
Usufruct assets
3.33%2.33M
1.71%2.47M
-8.82%2.17M
-7.06%2.21M
-8.52%2.25M
-1.39%2.43M
--2.38M
--2.38M
--2.46M
-6.38%2.46M
Other non current assets
215.45%34.77M
1,053.01%54.14M
439.88%40.9M
157.66%23.77M
-11.59%11.02M
-53.04%4.7M
-62.95%7.57M
-48.73%9.23M
-45.53%12.47M
-46.60%10M
Total non current assets
39.26%1.84B
35.93%1.8B
20.84%1.56B
19.75%1.55B
5.38%1.32B
10.98%1.33B
8.65%1.29B
9.82%1.29B
9.31%1.25B
5.68%1.19B
Total assets
25.68%3.88B
6.27%3.21B
0.78%3.05B
2.61%3.13B
2.49%3.09B
-1.12%3.02B
3.83%3.03B
5.11%3.05B
5.68%3.01B
4.43%3.06B
Liabilities
Current liabilities
Short term loan
--24.21M
141.94%24.22M
-60.21%14.2M
----
----
-80.72%10.01M
--35.68M
--53.69M
--51.8M
3.84%51.92M
Notes payable and accounts payable
113.57%205.74M
109.03%292.32M
-17.12%83.59M
72.13%187.53M
-22.79%96.34M
0.38%139.85M
6.98%100.87M
14.82%108.95M
13.00%124.77M
21.62%139.31M
-Notes payable
68.27%18.2M
39.92%19.01M
6.66%22.68M
-42.20%13.18M
-25.38%10.81M
-0.34%13.59M
323.65%21.27M
640.32%22.8M
82.04%14.49M
16.49%13.64M
-Accounts payable
119.29%187.54M
116.47%273.31M
-23.48%60.91M
102.39%174.35M
-22.45%85.52M
0.46%126.26M
-10.83%79.6M
-6.17%86.14M
7.64%110.28M
22.20%125.68M
Contract liabilities
-71.92%21.96M
-40.76%11.31M
-15.54%13.67M
-0.47%16.08M
366.73%78.17M
23.47%19.09M
-15.47%16.18M
-19.70%16.16M
-28.17%16.75M
-8.16%15.46M
Advance receipts
----
----
40,995.89%19.5M
31,512.22%15M
----
----
--47.45K
-99.83%47.45K
-98.81%47.45K
-99.86%47.45K
Salaries payable
2.84%18.14M
28.51%22.12M
18.26%16.97M
1.86%22.93M
16.61%17.64M
-12.93%17.21M
-1.74%14.35M
63.05%22.51M
18.57%15.13M
20.24%19.77M
Taxs payable
-56.02%4.88M
-1.95%17.18M
3.22%19.35M
-34.03%19.33M
-66.39%11.09M
-51.64%17.52M
-50.66%18.75M
-21.53%29.3M
-30.04%33M
20.08%36.22M
Other payable (including interest and dividends)
-93.77%2.66M
-42.71%5.6M
-42.06%4.98M
34.38%20.32M
144.21%42.74M
-72.37%9.78M
3.56%8.6M
80.07%15.12M
107.92%17.5M
289.01%35.41M
-Other payable
----
----
----
34.38%20.32M
----
-72.37%9.78M
----
80.07%15.12M
----
289.01%35.41M
Non current liabilities due within one year
142,649.37%211.98M
71,784.91%207.93M
-38.08%150.32K
-38.83%148.5K
1.23%148.5K
97.17%289.26K
--242.75K
--242.75K
--146.7K
149.14%146.7K
Other current liabilities
-71.39%3.81M
-65.04%3.24M
-24.89%6.77M
37.82%6.82M
39.28%13.33M
-31.59%9.27M
263.11%9.02M
99.99%4.95M
359.92%9.57M
632.80%13.55M
Total current liabilities
90.16%493.38M
161.83%583.92M
-12.05%179.19M
14.82%288.17M
-3.44%259.45M
-28.48%223.01M
15.22%203.74M
20.16%250.98M
29.09%268.7M
11.28%311.83M
Current liabilities
Bonds payable
----
----
6.39%206.27M
6.38%202.29M
6.79%201.99M
6.49%197.68M
6.47%193.88M
6.44%190.16M
6.73%189.15M
6.76%185.64M
Deferred tax liabilities
-4.20%27.43M
-6.75%27.73M
-0.59%29.16M
-3.39%28.59M
-4.99%28.63M
-1.32%29.74M
-4.39%29.33M
-3.51%29.6M
-4.25%30.14M
-18.32%30.14M
Long term deferred income
1.07%80.2M
1.07%80.2M
0.00%79.36M
0.00%79.36M
0.00%79.36M
0.00%79.36M
5.17%79.36M
4.63%79.36M
4.09%79.36M
--79.36M
Lease liabilities
-6.60%2.13M
-6.60%2.13M
-6.65%2.13M
-6.57%2.13M
-6.12%2.28M
-6.12%2.28M
--2.28M
--2.28M
--2.42M
-5.70%2.42M
Total non current liabilities
-64.85%109.76M
-64.39%110.06M
3.96%316.91M
3.64%312.37M
3.72%312.26M
3.86%309.06M
5.76%304.85M
5.69%301.4M
5.67%301.07M
39.47%297.56M
Total liabilities
5.50%603.14M
30.43%693.98M
-2.46%496.1M
8.72%600.54M
0.34%571.71M
-12.69%532.07M
9.36%508.59M
11.81%552.37M
15.55%569.78M
23.46%609.39M
Shareholders equity
Paid-in capital
23.60%901.81M
0.00%729.6M
0.00%729.6M
0.00%729.6M
0.00%729.6M
0.00%729.6M
0.00%729.6M
0.00%729.59M
0.00%729.59M
0.00%729.59M
Other equity instruments
-0.01%53.23M
-0.01%53.23M
-0.00%53.24M
-0.01%53.24M
-0.01%53.24M
-0.03%53.24M
-0.05%53.24M
-0.07%53.24M
-0.07%53.24M
-0.05%53.25M
Capital reserve funds
100.13%962.22M
-0.61%481.22M
0.04%480.8M
0.43%480.79M
0.82%480.79M
1.93%484.19M
1.45%480.6M
1.07%478.74M
0.13%476.9M
-0.19%475.01M
Surplus reserve funds
4.14%220.01M
4.84%220.01M
5.79%209.8M
5.79%209.8M
6.53%211.27M
5.81%209.85M
9.47%198.32M
9.47%198.32M
9.47%198.32M
9.47%198.32M
Retained profit
-0.07%1.18B
2.02%1.18B
1.75%1.22B
1.17%1.2B
4.59%1.19B
1.41%1.16B
3.97%1.2B
6.31%1.19B
6.36%1.13B
7.74%1.14B
Less:Treasury stock
--0
0.00%100.08M
0.00%100.08M
0.00%100.08M
0.00%100.08M
0.00%100.08M
0.00%100.08M
0.00%100.08M
0.00%100.08M
223.27%100.08M
Other composite income
0.30%-52.59M
0.30%-52.59M
-0.29%-52.75M
-0.29%-52.75M
-0.11%-52.75M
-0.29%-52.75M
-5.83%-52.6M
-5.83%-52.6M
-6.02%-52.7M
-5.83%-52.6M
Shareholders equity without minority interests
30.38%3.27B
1.24%2.51B
1.30%2.54B
1.09%2.52B
2.82%2.51B
1.50%2.48B
2.74%2.51B
3.73%2.49B
3.51%2.44B
1.08%2.44B
Minority interests
-2.53%8.56M
-24.97%8.81M
59.57%9.21M
89.82%8.81M
96.95%8.78M
126.81%11.74M
23.39%5.77M
3.83%4.64M
136.20%4.46M
-69.97%5.18M
Total shareholder equity
30.27%3.28B
1.11%2.52B
1.43%2.55B
1.26%2.53B
2.99%2.52B
1.77%2.49B
2.78%2.52B
3.73%2.5B
3.61%2.44B
0.58%2.45B
Total liabilityies and equity
25.68%3.88B
6.27%3.21B
0.78%3.05B
2.61%3.13B
2.49%3.09B
-1.12%3.02B
3.83%3.03B
5.11%3.05B
5.68%3.01B
4.43%3.06B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 28.93%1.48B-19.66%912.9M-19.13%912.74M-7.02%1.04B3.82%1.15B-10.44%1.14B2.76%1.13B5.77%1.12B1.78%1.11B11.84%1.27B
Transactional financial assets -13.89%94.03M-0.38%100.8M6.21%104.84M-16.29%103.1M10.09%109.19M-18.80%101.18M-25.02%98.71M-8.02%123.16M-27.74%99.18M-31.02%124.61M
Notes receivable and accounts receivable -28.13%124.03M31.90%120.11M-8.40%123.74M-7.41%117.96M32.60%172.58M-18.93%91.06M20.27%135.08M32.10%127.41M42.13%130.15M50.92%112.32M
-Notes receivable 9.07%10.54M11.99%24.57M5.83%13.16M2.26%13.33M-20.36%9.67M-9.46%21.94M3,178.18%12.43M3,972.80%13.03M5,509.11%12.14M14,152.52%24.24M
-Accounts receivable -30.34%113.49M38.22%95.53M-9.84%110.58M-8.52%104.63M38.05%162.92M-21.54%69.12M9.57%122.65M18.98%114.38M29.18%118.01M18.63%88.09M
Other receivables (including interest and dividends) 89.39%27.65M-37.60%24.79M-96.96%1.61M-73.19%14.79M-76.09%14.6M35.97%39.72M1,544.19%52.97M2,361.84%55.16M3,536.44%61.06M1,701.74%29.21M
-Accrued interest receivable --------------0------------------------
-Other receivable -------------73.19%14.79M----35.97%39.72M----2,361.84%55.16M----1,701.74%29.21M
Advance payment 37.57%47.46M46.13%20.76M202.42%37.18M60.91%23.85M58.45%34.5M-2.25%14.21M-78.54%12.29M-64.40%14.82M-46.68%21.77M-64.81%14.53M
Inventories -19.62%220.31M-35.86%193.96M-2.08%291.52M-14.42%262.58M-11.55%274.11M5.55%302.39M0.78%297.72M4.20%306.82M22.94%309.91M46.02%286.48M
Receivable financing -65.56%1.84M-15.73%3.09M499.63%6.32M97.98%6.85M88.51%5.36M-29.83%3.66M-84.80%1.05M-76.56%3.46M-68.21%2.84M-77.46%5.22M
Other current assets 433.48%46.14M283.34%34.22M30.72%14.97M47.83%15.07M-69.87%8.65M-58.69%8.93M-51.53%11.45M-56.89%10.2M23.82%28.71M-25.24%21.61M
Total current assets 15.55%2.04B-16.90%1.41B-14.10%1.49B-9.96%1.58B0.44%1.77B-8.87%1.7B0.53%1.74B1.89%1.76B3.24%1.76B3.65%1.86B
Non Current assets
Other equity investment 2.22%7.4M2.22%7.4M-2.14%7.24M-2.14%7.24M-0.87%7.24M-2.14%7.24M-37.28%7.4M-46.16%7.4M-40.34%7.3M-39.56%7.4M
Other non-current financial assets -0.18%31.62M-0.18%31.62M1,714.85%31.67M1,714.85%31.67M1,695.45%31.67M1,684.62%31.67M-32.87%1.75M-32.87%1.75M-32.15%1.76M-31.74%1.77M
Investment real estate --------44.61%123.02M44.55%124.48M47.16%125.93M47.09%127.38M21.61%85.07M21.67%86.12M18.76%85.57M19.58%86.6M
Long-term equity investment -0.67%77.33M-16.80%64.78M-11.34%76.02M-11.09%76.73M4.76%77.86M130.66%77.86M204.23%85.73M2,837.38%86.29M--74.32M--33.75M
Fixed assets -------------11.27%499.85M-----6.71%519.35M-----5.02%563.34M----2.92%556.68M
Constru in process ------------213.21%390.5M----97.12%159.74M----121.19%124.68M----0.11%81.04M
Productive biological assets -3.64%135.37M-3.61%136.65M-3.58%137.93M-3.54%139.21M-4.25%140.49M-3.48%141.77M-3.45%143.05M-3.42%144.33M-2.65%146.73M-3.36%146.88M
Intangible assets 8.32%220.8M0.03%206.05M-7.26%201.41M-7.31%202.54M-7.38%203.83M-6.99%205.99M-3.11%217.17M-3.32%218.52M-2.39%220.07M-2.61%221.48M
Development expenditure --------------------------0--0--------
Goodwill --157.93K--157.93K--------------------------------
Long deferred expense 26.98%4.31M47.52%4.61M103.80%5.75M-11.93%2.91M-15.89%3.39M-33.71%3.13M-11.71%2.82M-5.68%3.31M-2.87%4.03M-3.36%4.72M
Deferred tax assets 22.84%52.37M9.74%49.14M-11.71%43.73M2.57%44.12M-12.51%42.63M6.55%44.78M29.08%49.53M12.04%43.02M38.98%48.73M164.80%42.02M
Usufruct assets 3.33%2.33M1.71%2.47M-8.82%2.17M-7.06%2.21M-8.52%2.25M-1.39%2.43M--2.38M--2.38M--2.46M-6.38%2.46M
Other non current assets 215.45%34.77M1,053.01%54.14M439.88%40.9M157.66%23.77M-11.59%11.02M-53.04%4.7M-62.95%7.57M-48.73%9.23M-45.53%12.47M-46.60%10M
Total non current assets 39.26%1.84B35.93%1.8B20.84%1.56B19.75%1.55B5.38%1.32B10.98%1.33B8.65%1.29B9.82%1.29B9.31%1.25B5.68%1.19B
Total assets 25.68%3.88B6.27%3.21B0.78%3.05B2.61%3.13B2.49%3.09B-1.12%3.02B3.83%3.03B5.11%3.05B5.68%3.01B4.43%3.06B
Liabilities
Current liabilities
Short term loan --24.21M141.94%24.22M-60.21%14.2M---------80.72%10.01M--35.68M--53.69M--51.8M3.84%51.92M
Notes payable and accounts payable 113.57%205.74M109.03%292.32M-17.12%83.59M72.13%187.53M-22.79%96.34M0.38%139.85M6.98%100.87M14.82%108.95M13.00%124.77M21.62%139.31M
-Notes payable 68.27%18.2M39.92%19.01M6.66%22.68M-42.20%13.18M-25.38%10.81M-0.34%13.59M323.65%21.27M640.32%22.8M82.04%14.49M16.49%13.64M
-Accounts payable 119.29%187.54M116.47%273.31M-23.48%60.91M102.39%174.35M-22.45%85.52M0.46%126.26M-10.83%79.6M-6.17%86.14M7.64%110.28M22.20%125.68M
Contract liabilities -71.92%21.96M-40.76%11.31M-15.54%13.67M-0.47%16.08M366.73%78.17M23.47%19.09M-15.47%16.18M-19.70%16.16M-28.17%16.75M-8.16%15.46M
Advance receipts --------40,995.89%19.5M31,512.22%15M----------47.45K-99.83%47.45K-98.81%47.45K-99.86%47.45K
Salaries payable 2.84%18.14M28.51%22.12M18.26%16.97M1.86%22.93M16.61%17.64M-12.93%17.21M-1.74%14.35M63.05%22.51M18.57%15.13M20.24%19.77M
Taxs payable -56.02%4.88M-1.95%17.18M3.22%19.35M-34.03%19.33M-66.39%11.09M-51.64%17.52M-50.66%18.75M-21.53%29.3M-30.04%33M20.08%36.22M
Other payable (including interest and dividends) -93.77%2.66M-42.71%5.6M-42.06%4.98M34.38%20.32M144.21%42.74M-72.37%9.78M3.56%8.6M80.07%15.12M107.92%17.5M289.01%35.41M
-Other payable ------------34.38%20.32M-----72.37%9.78M----80.07%15.12M----289.01%35.41M
Non current liabilities due within one year 142,649.37%211.98M71,784.91%207.93M-38.08%150.32K-38.83%148.5K1.23%148.5K97.17%289.26K--242.75K--242.75K--146.7K149.14%146.7K
Other current liabilities -71.39%3.81M-65.04%3.24M-24.89%6.77M37.82%6.82M39.28%13.33M-31.59%9.27M263.11%9.02M99.99%4.95M359.92%9.57M632.80%13.55M
Total current liabilities 90.16%493.38M161.83%583.92M-12.05%179.19M14.82%288.17M-3.44%259.45M-28.48%223.01M15.22%203.74M20.16%250.98M29.09%268.7M11.28%311.83M
Current liabilities
Bonds payable --------6.39%206.27M6.38%202.29M6.79%201.99M6.49%197.68M6.47%193.88M6.44%190.16M6.73%189.15M6.76%185.64M
Deferred tax liabilities -4.20%27.43M-6.75%27.73M-0.59%29.16M-3.39%28.59M-4.99%28.63M-1.32%29.74M-4.39%29.33M-3.51%29.6M-4.25%30.14M-18.32%30.14M
Long term deferred income 1.07%80.2M1.07%80.2M0.00%79.36M0.00%79.36M0.00%79.36M0.00%79.36M5.17%79.36M4.63%79.36M4.09%79.36M--79.36M
Lease liabilities -6.60%2.13M-6.60%2.13M-6.65%2.13M-6.57%2.13M-6.12%2.28M-6.12%2.28M--2.28M--2.28M--2.42M-5.70%2.42M
Total non current liabilities -64.85%109.76M-64.39%110.06M3.96%316.91M3.64%312.37M3.72%312.26M3.86%309.06M5.76%304.85M5.69%301.4M5.67%301.07M39.47%297.56M
Total liabilities 5.50%603.14M30.43%693.98M-2.46%496.1M8.72%600.54M0.34%571.71M-12.69%532.07M9.36%508.59M11.81%552.37M15.55%569.78M23.46%609.39M
Shareholders equity
Paid-in capital 23.60%901.81M0.00%729.6M0.00%729.6M0.00%729.6M0.00%729.6M0.00%729.6M0.00%729.6M0.00%729.59M0.00%729.59M0.00%729.59M
Other equity instruments -0.01%53.23M-0.01%53.23M-0.00%53.24M-0.01%53.24M-0.01%53.24M-0.03%53.24M-0.05%53.24M-0.07%53.24M-0.07%53.24M-0.05%53.25M
Capital reserve funds 100.13%962.22M-0.61%481.22M0.04%480.8M0.43%480.79M0.82%480.79M1.93%484.19M1.45%480.6M1.07%478.74M0.13%476.9M-0.19%475.01M
Surplus reserve funds 4.14%220.01M4.84%220.01M5.79%209.8M5.79%209.8M6.53%211.27M5.81%209.85M9.47%198.32M9.47%198.32M9.47%198.32M9.47%198.32M
Retained profit -0.07%1.18B2.02%1.18B1.75%1.22B1.17%1.2B4.59%1.19B1.41%1.16B3.97%1.2B6.31%1.19B6.36%1.13B7.74%1.14B
Less:Treasury stock --00.00%100.08M0.00%100.08M0.00%100.08M0.00%100.08M0.00%100.08M0.00%100.08M0.00%100.08M0.00%100.08M223.27%100.08M
Other composite income 0.30%-52.59M0.30%-52.59M-0.29%-52.75M-0.29%-52.75M-0.11%-52.75M-0.29%-52.75M-5.83%-52.6M-5.83%-52.6M-6.02%-52.7M-5.83%-52.6M
Shareholders equity without minority interests 30.38%3.27B1.24%2.51B1.30%2.54B1.09%2.52B2.82%2.51B1.50%2.48B2.74%2.51B3.73%2.49B3.51%2.44B1.08%2.44B
Minority interests -2.53%8.56M-24.97%8.81M59.57%9.21M89.82%8.81M96.95%8.78M126.81%11.74M23.39%5.77M3.83%4.64M136.20%4.46M-69.97%5.18M
Total shareholder equity 30.27%3.28B1.11%2.52B1.43%2.55B1.26%2.53B2.99%2.52B1.77%2.49B2.78%2.52B3.73%2.5B3.61%2.44B0.58%2.45B
Total liabilityies and equity 25.68%3.88B6.27%3.21B0.78%3.05B2.61%3.13B2.49%3.09B-1.12%3.02B3.83%3.03B5.11%3.05B5.68%3.01B4.43%3.06B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg